Bleeding complications in primary percutaneous coronary intervention of ST-elevation myocardial infarction in a radial center

Catheterization and Cardiovascular Interventions

Volumn 79, Issue 1, 2012, Pages 104-112

  Barthélémy, Olivier ^a   Silvain, Johanne ^a   Brieger, David ^a,b   Mercadier, Anne ^c   Lancar, Remi ^d   Bellemain Appaix, Anne ^a   Beygui, Farzin ^a   Collet, Jean Philippe ^a   Costagliola, Dominique ^d   Montalescot, Gilles ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^b UNIVERSITY OF SYDNEY   (Australia)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d INSERM   (France)

Author keywords

angioplasty; bleeding; hemorrhage; prognosis; ST elevation myocardial infarction

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; AGED; ARTICLE; CARDIOGENIC SHOCK; CONTROLLED STUDY; FEMALE; FIBRINOLYSIS; GASTROINTESTINAL HEMORRHAGE; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUT OF HOSPITAL CARDIAC ARREST; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; REGISTER; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84355163105     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.23164     Document Type: Article

References (34)

1. Fox KA, Steg PG, Eagle KA, Goodman SG, Anderson FA Jr, Granger CB, Flather MD, Budaj A, Quill A, Gore JM,. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA 2007; 297: 1892-1900. (Pubitemid 46707843)
2. Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC,. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: A 10-year trend analysis. J Am Coll Cardiol 2008; 51: 1247-1254. (Pubitemid 351400891)
3. Moscucci M, Fox KA, Cannon CP, Klein W, Lopez-Sendon J, Montalescot G, White K, Goldberg RJ,. Predictors of major bleeding in acute coronary syndromes: The global registry of acute coronary events (GRACE). Eur Heart J 2003; 24: 1815-1823. (Pubitemid 37280247)
4. Ellis SG, Tendera M, de Belder MA, van Boven AJ, Widimsky P, Janssens L, Andersen HR, Betriu A, Savonitto S, Adamus J, et al. Facilitated PCI in patients with ST-elevation myocardial infarction. N Engl J Med 2008; 358: 2205-2217. (Pubitemid 351724450)
5. Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, et al. Bivalirudin during primary PCI in acute myocardial infarction. N Engl J Med 2008; 358: 2218-2230. (Pubitemid 351724451)
6. Vorobcsuk A, Konyi A, Aradi D, Horvath IG, Ungi I, Louvard Y, Komocsi A,. Transradial versus transfemoral percutaneous coronary intervention in acute myocardial infarction. Systematic overview and meta-analysis. Am Heart J 2009; 158: 814-821.
7. Rao AK, Pratt C, Berke A, Jaffe A, Ockene I, Schreiber TL, Bell WR, Knatterud G, Robertson TL, Terrin ML,. Thrombolysis in myocardial infarction (TIMI) trial-Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Coll Cardiol 1988; 11: 1-11. (Pubitemid 18029027)
8. Steinhubl SR, Kastrati A, Berger PB,. Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs. Am Heart J 2007; 154: 3-11. (Pubitemid 46924806)
9. Manoukian SV, Feit F, Mehran R, Voeltz MD, Ebrahimi R, Hamon M, Dangas GD, Lincoff AM, White HD, Moses JW, et al. Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: An analysis from the ACUITY trial. J Am Coll Cardiol 2007; 49: 1362-1368. (Pubitemid 46476844)
10. Budaj A, Eikelboom JW, Mehta SR, Afzal R, Chrolavicius S, Bassand JP, Fox KA, Wallentin L, Peters RJ, Granger CB, et al. Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. Eur Heart J 2009; 30: 655-661.
11. Eikelboom JW, Mehta SR, Anand SS, Xie C, Fox KA, Yusuf S,. Adverse impact of bleeding on prognosis in patients with acute coronary syndromes. Circulation 2006; 114: 774-782. (Pubitemid 44268228)
12. Rao SV, O'Grady K, Pieper KS, Granger CB, Newby LK, Van de Werf F, Mahaffey KW, Califf RM, Harrington RA,. Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes. Am J Cardiol 2005; 96: 1200-1206. (Pubitemid 41505393)
13. Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, Boulenc JM, Morice MC, Maillard L, Pansieri M, et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001; 344: 1895-1903. (Pubitemid 32553358)
14. Brieger D, Collet JP, Silvain J, Landivier A, Barthelemy O, Beygui F, Bellemain-Appaix A, Mercadier A, Choussat R, Vignolles N, et al. Heparin or enoxaparin anticoagulation for primary percutaneous coronary intervention. Catheter Cardiovasc Interv 2011; 77: 182-190.
15. Montalescot G, Gallo R, White HD, Cohen M, Steg PG, Aylward PE, Bode C, Chiariello M, King SB III, Harrington RA, et al. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention 1-year results from the STEEPLE (SafeTy and efficacy of enoxaparin in percutaneous coronary intervention patients, an international randomized evaluation) trial. JACC Cardiovasc Interv 2009; 2: 1083-1091.
16. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329: 673-682.
17. Hetherington SL, Adam Z, Morley R, de Belder MA, Hall JA, Muir DF, Sutton AG, Swanson N, Wright RA,. Primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: Changing patterns of vascular access, radial versus femoral artery. Heart 2009; 95: 1612-1618.
18. Kandzari DE, Hasselblad V, Tcheng JE, Stone GW, Califf RM, Kastrati A, Neumann FJ, Brener SJ, Montalescot G, Kong DF, et al. Improved clinical outcomes with abciximab therapy in acute myocardial infarction: A systematic overview of randomized clinical trials. Am Heart J 2004; 147: 457-462. (Pubitemid 38880865)
19. Yusuf S, Mehta SR, Chrolavicius S, Afzal R, Pogue J, Granger CB, Budaj A, Peters RJ, Bassand JP, Wallentin L, et al. Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: The OASIS-6 randomized trial. JAMA 2006; 295: 1519-1530.
20. Montalescot G, Ellis SG, De Belder MA, Janssens L, Katz O, Pluta W, Ecollan P, Tendera M, Van Boven AJ, Widimsky P, et al. Enoxaparin in primary and facilitated percutaneous coronary intervention. A formal prospective nonrandomized substudy of the FINESSE (Facilitated INtervention with Enhanced Reperfusion Speed to Stop Events) trial. JACC Cardiovasc Interv 2010; 3: 203-212.
21. Spencer FA, Moscucci M, Granger CB, Gore JM, Goldberg RJ, Steg PG, Goodman SG, Budaj A, FitzGerald G, Fox KA,. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation 2007; 116: 2793-2801. (Pubitemid 350291221)
22. Cantor WJ, Fitchett D, Borgundvaag B, Ducas J, Heffernan M, Cohen EA, Morrison LJ, Langer A, Dzavik V, Mehta SR, et al. Routine early angioplasty after fibrinolysis for acute myocardial infarction. N Engl J Med 2009; 360: 2705-2718.
23. Stone GW, McLaurin BT, Cox DA, Bertrand ME, Lincoff AM, Moses JW, White HD, Pocock SJ, Ware JH, Feit F, et al. Bivalirudin for patients with acute coronary syndromes. N Engl J Med 2006; 355: 2203-2216. (Pubitemid 44791162)
24. Abraham NS, Hlatky MA, Antman EM, Bhatt DL, Bjorkman DJ, Clark CB, Furberg CD, Johnson DA, Kahi CJ, Laine L, et al. ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: A focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. J Am Coll Cardiol 2010; 56: 2051-2066.
25. Rao SV, O'Grady K, Pieper KS, Granger CB, Newby LK, Mahaffey KW, Moliterno DJ, Lincoff AM, Armstrong PW, Van de Werf F, et al. A comparison of the clinical impact of bleeding measured by two different classifications among patients with acute coronary syndromes. J Am Coll Cardiol 2006; 47: 809-816. (Pubitemid 43243106)
26. Rao SV, Jollis JG, Harrington RA, Granger CB, Newby LK, Armstrong PW, Moliterno DJ, Lindblad L, Pieper K, Topol EJ, et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA 2004; 292: 1555-1562. (Pubitemid 39314961)
27. Wang TY, Xiao L, Alexander KP, Rao SV, Kosiborod MN, Rumsfeld JS, Spertus JA, Peterson ED,. Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding. Circulation 2008; 118: 2139-2145.
28. Sabatine MS, Morrow DA, Giugliano RP, Burton PB, Murphy SA, McCabe CH, Gibson CM, Braunwald E,. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005; 111: 2042-2049. (Pubitemid 40577898)
29. Mehran R, Pocock SJ, Stone GW, Clayton TC, Dangas GD, Feit F, Manoukian SV, Nikolsky E, Lansky AJ, Kirtane A, et al. Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: A risk model from the ACUITY trial. Eur Heart J 2009; 30: 1457-1466.
30. Rao SV, Ou FS, Wang TY, Roe MT, Brindis R, Rumsfeld JS, Peterson ED,. Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: A report from the National Cardiovascular Data Registry. JACC Cardiovasc Interv 2008; 1: 379-386.
31. Jolly SS, Amlani S, Hamon M, Yusuf S, Mehta SR,. Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: A systematic review and meta-analysis of randomized trials. Am Heart J 2009; 157: 132-140.
32. Chase AJ, Fretz EB, Warburton WP, Klinke WP, Carere RG, Pi D, Berry B, Hilton JD,. Association of the arterial access site at angioplasty with transfusion and mortality: The M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after percutaneous coronary intervention via the Arm or Leg). Heart 2008; 94: 1019-1025. (Pubitemid 352039884)
33. Montalescot G, Ongen Z, Guindy R, Sousa A, Lu SZ, Pahlajani D, Pellois A, Vicaut E,. Predictors of outcome in patients undergoing PCI. Results of the RIVIERA study. Int J Cardiol 2008; 129: 379-387.
34. Montalescot G, Cayla G, Collet JP, Elhadad S, Beygui F, Le Breton H, Choussat R, Leclercq F, Silvain J, Duclos F, et al. Immediate vs. delayed intervention for acute coronary syndromes: A randomized clinical trial. JAMA 2009; 302: 947-954.